Escalon Medical (OTCMKTS:ESMC) Issues Earnings Results

Escalon Medical (OTCMKTS:ESMC – Get Free Report) released its quarterly earnings data on Tuesday. The medical equipment provider reported $0.12 EPS for the quarter, Zacks reports. Escalon Medical had a net margin of 16.17% and a negative return on equity of 21.42%.

Escalon Medical Price Performance

Escalon Medical stock traded up $0.01 during mid-day trading on Tuesday, reaching $0.17. The company had a trading volume of 30,060 shares, compared to its average volume of 19,084. The stock’s 50-day simple moving average is $0.17 and its 200-day simple moving average is $0.18. Escalon Medical has a 1 year low of $0.14 and a 1 year high of $0.28. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.59 and a quick ratio of 1.94. The company has a market capitalization of $1.22 million, a P/E ratio of 1.50 and a beta of 0.51.

About Escalon Medical

(Get Free Report)

Escalon Medical Corp. is a medical-device company focused on products for the ophthalmic surgical market. The company develops, manufactures and markets devices and related products used by eye-care professionals, particularly in procedures involving the retina and vitreous.

Its product offerings have included ophthalmic surgical instruments, delivery systems and products used in retinal surgery, such as intraocular gases, silicone oils and other retinal tamponade materials. These products are designed to support procedures for treating retinal detachments and other serious eye conditions.

Escalon Medical has historically served ophthalmic surgeons and medical institutions through markets in the United States and internationally.

Read More

Earnings History for Escalon Medical (OTCMKTS:ESMC)

Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.